Type
Levis W, Spencer T, Ladizinski B. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York. Journal of drugs in dermatology : JDD. 2010;9(8):906.
Type
Martins PV, Caponi S. [Hansen's disease, exclusion and prejudice: life histories of women at Santa Catarina State]. Ciencia & saude coletiva [Internet]. 2010;15 Suppl 1:1047-54. Available from: http://www.scielo.br/pdf/csc/v15s1/011.pdf
Type
Abraham, John, Rao, Papang. A study of steroid-induced diabetes mellitus in leprosy. Indian journal of leprosy [Internet]. 2009;81(3):125-9. Available from: http://www.ijl.org.in/July-Sept%202009_PDF%20Files/3_Abst%20(125-130).pdf
Type
Pai V, Girdhar, Hanumanthayya, Tophakhane. Response of patients with nerve function impairment in leprosy to low dose steroid administration: an outpatient based study. Indian journal of dermatology, venereology and leprology. 2010;76(4):408-9.
Type
Sapkota B, Macdonald M, Berrington W, Misch A, Ranjit C, Siddiqui R, et al. Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Human immunology. 2010;71(10):992-8.
Type
Motta AC, Furini RB, Simão JCL, Ferreira MAN, Komesu M, Foss N. The recurrence of leprosy reactional episodes could be associated with oral chronic infections and expression of serum IL-1, TNF-alpha, IL-6, IFN-gamma and IL-10. Brazilian dental journal. 2010;21(2):158-64.
Type
Crawford C. Historical aspects of leprosy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Internet]. 2010;51(4):476-7; discussion 477. Available from: http://cid.oxfordjournals.org/content/51/4/476.full.pdf+html?sid=cfa3a695-e4df-42b6-92e2-a55040ed6811
Type
Suzuki K, Udono T, Fujisawa M, Tanigawa K, Idani G'ichi, Ishii N. Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical research. Journal of clinical microbiology [Internet]. 2010;48(9):3432-4. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937736/pdf/0017-10.pdf
Type
Wong S, Gochhait S, Malhotra D, Pettersson F, Teo Y, Khor C, et al. Leprosy and the adaptation of human toll-like receptor 1. PLoS pathogens. 2010;6:e1000979.
Type
Singh K, Singh B, Ray P. Anti-ceramide antibodies in leprosy: marker for nerve damage?. Journal of infection in developing countries [Internet]. 2010;4(6):378-81. Available from: http://www.jidc.org/index.php/journal/article/view/20601789